The influenza virus is a member of the Orthomyxoviridae family of segmented, single-stranded, negatively charged RNA viruses. Three different influenza virus types—A, B, and C—are included in this group. The type A viruses infect both domesticated and wild birds, horses, swine, other mammals, and humans, while the type B and C viruses only affect humans.In the United States, seasonal epidemics of disease are brought on by human influenza A and B viruses almost every winter. An influenza pandemic can be brought on by the spread of a brand-new, radically different influenza virus. Infections with influenza type C are thought to only cause a mild respiratory illness and not epidemics. Each virus subtype has undergone mutation, resulting in a variety of strains with various levels of pathogenicity; some are pathogenic to one species but not to others, and some are pathogenic to several.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V84540 | Urolithin M5 (Decarboxyellagic acid) | 91485-02-8 | |
|
V54356 | Urumin | 2215863-74-2 | Urumin has antiviral effect against human influenza A virus. |
|
V76065 | XSJ2-46 | 2265911-12-2 | XSJ2-46, a 5'-aminoNI analog, is an antiviral compound. |
|
V54349 | Yadanziolide B | 95258-13-2 | Yadanziolide B is a natural quasinoid compound that is a potential H5N1 neuraminidase inhibitor. |
|
V54335 | Zanamivir-Cholesterol Conjugate | 2478446-18-1 | Zanamivir–cholesterol conjugate is a long-acting neuraminidase inhibitor (antagonist) with potent efficacy against drug-resistant influenza viruses. |
|
V35103 | Zapnometinib (PD0184264; ATR-002) | 303175-44-2 | Zapnometinib (PD0184264), the bioactive metabolite of CI-1040, is a MEK inhibitor (antagonist) with IC50 of 5.7 nM. |
|
V85394 | ZIKV-IN-8 | 3022924-04-2 | |
|
V12559 | Beta-Cyclodextrin | 7585-39-9 | Beta-Cyclodextrin is a novel and potent cyclic heptamer/cyclic oligosaccharide produced from starch via enzymatic conversion. |
|
V31258 | Cephalotaxlen (ZINC19795976) | 24316-19-6 | Cephalotaxine (Cephalotaxlen; ZINC-19795976) is a novel and potent antiviral agent with antitumor activity. |
|
V20830 | Harringtonine | 26833-85-2 | Harringtonine is anatural Cephalotaxus alkaloid found in Cephalotaxuts. |
|
V21476 | Umifenovir | 131707-25-0 | Umifenovir (trade name Arbidol) is a broad-spectrum antiviral drug that inhibits viral fusion, and has been approved for use in Russia and China for the treatment of influenza and other respiratory viral infections. |
|
V28136 | VX-787 (Pimodivir) | 1629869-44-8 | Pimodivir (formerly VX787; JNJ872; VRT-0928787;VX-787; JNJ-872) is a novel and orally bioavailable inhibitor of influenza virus replication by blocking the PB2 cap-snatching activity of the influenza viral polymerase complex. |
|
V30214 | Impulsin | 544-31-0 | Palmitoylethanolamide (Palmidrol) is an endogenous active compound used to prevent respiratory viral infections. |
|
V21560 | Germacrone | 6902-91-6 | Germacrone is found in turmeric and inhibits influenza virus infection. |
|
V0094 | Baloxavir (Xofluza; BXA; S033447) | 1985605-59-1 | Baloxavir(trade name Xofluza;also known asBaloxaviracid, BXA,or S-033447),derived from the prodrug baloxavir marboxil (BXM), is an orally available small molecule inhibitor of the cap-dependent endonuclease. |
|
V0095 | Baloxavir marboxil (BXM, S033188) | 1985606-14-1 | Baloxavir marboxil (BXM or S-033188) is the prodrug ofBaloxavir(trade name Xofluza;also known asBaloxaviracid, BXA,or S-033447) which is an approved antiviral drug developed by Roche and Shionogi as an anti-influenza agent for treatment of influenza A and influenza B flu. |
|
V9167 | Peramivir (BCX-1812, RWJ-270201, S-021812) | 330600-85-6 | Peramivir (formerly RWJ270201;BCX1812; S021812; Rapivab; Rapiacta; Peramiflu)is an antiviral agent acting as a neuraminidase inhibitor and has been approved for treating influenza. |
|
V2442 | Peramivir Trihydrate (RWJ-270201; BCX-1812) | 1041434-82-5 | Peramivir Trihydrate (also known as BCX-1812, RWJ-270201, S-021812; trade name Rapivab)is a trihydrate form of the antiviral agent peramivirwhich is a transition-state analogue and a specific influenza viral neuraminidase inhibitor approved for the treatment of influenza. |
|
V20639 | Zanamivir | 139110-80-8 | Zanamivir (GR-121167X; GG-167; Relenza) is a novel and potent neuraminidase inhibitor with antiviral activity againstinfluenza. |
|
V5767 | Laninamivir (Inavir, CS8958, R125489) | 203120-17-6 | Laninamivir (Inavir, CS-8958,R-125489) is a novel and potent neuraminidase inhibitor with antiviral activities. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
